DG
ABBV icon

DMC Group’s AbbVie ABBV Stock Holding History

DMC Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Sell
5,543
-1,088
-16% -$234K 0.96% 28
2026
Q1 		$1.44M Buy
6,631
+642
+11% +$142K 0.97% 28
2025
Q4 		$1.37M Buy
5,989
+223
+4% +$50.8K 0.91% 31
2025
Q3 		$1.34M Buy
5,766
+140
+2% +$28.5K 0.92% 29
2025
Q2 		$1.04M Sell
5,626
-37
-0.7% -$6.88K 0.81% 37
2025
Q1 		$1.19M Sell
5,663
-3
-0.1% -$583 0.97% 29
2024
Q4 		$1.01M Sell
5,666
-50
-0.9% -$9.19K 0.82% 38
2024
Q3 		$1.13M Sell
5,716
-36
-0.6% -$6.72K 0.91% 33
2024
Q2 		$987K Buy
5,752
+285
+5% +$47.2K 0.85% 43
2024
Q1 		$996K Buy
5,467
+28
+0.5% +$4.83K 0.86% 39
2023
Q4 		$843K Sell
5,439
-166
-3% -$24.2K 0.8% 43
2023
Q3 		$835K Hold
5,605
– – 0.78% 39
2023
Q2 		$755K Sell
5,605
-36
-0.6% -$5.28K 0.76% 46
2023
Q1 		$905K Buy
5,641
+870
+18% +$133K 0.91% 33
2022
Q4 		$775K Buy
4,771
+840
+21% +$129K 0.87% 36
2022
Q3 		$544K Sell
3,931
-112
-3% -$16.1K 0.66% 45
2022
Q2 		$621K Buy
4,043
+23
+0.6% +$3.52K 0.74% 41
2022
Q1 		$623K Buy
4,020
+177
+5% +$25.7K 0.7% 45
2021
Q4 		$522K Buy
+3,843
New +$454K 0.45% 64

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DMC Group's ABBV Position: Q2 2026 in Review

DMC Group reduced its AbbVie (ABBV) stake by 16% in Q2 2026, selling an estimated $234K and leaving 5,543 shares worth $1.39M. The position accounts for 0.96% of the portfolio, ranked #28.

DMC Group first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.44M in Q1 2026. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • DMC Group held 5,543 shares of AbbVie worth $1.39M as of Q2 2026.
  • DMC Group sold 1,088 AbbVie shares in Q2 2026, an estimated $234K.
  • AbbVie made up 0.96% of DMC Group's portfolio in Q2 2026, its #28 holding.
  • DMC Group first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • DMC Group's AbbVie position peaked at $1.44M in Q1 2026.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DMC Group's 13F filing for Q2 2026, filed 28 Jul 2026.